|
Approximately 1 in every 500 people has Hypertrophic
Cardiomyopathy causing some,
including athletes, to die suddenly. Yet most people
are unaware of this inherited serious heart disease
and its potentially catastrophic effects. The Hypertrophic Cardiomyopathy Research Foundation, supporting research at St. Luke's Roosevelt Hospital Center, Columbia University, New York City, was started by an ex-athlete, one of the five percent who survive a sudden cardiac arrest. It is a New York State Tax Exempt Corporation under section 501(a) of the IRS code. After accounting costs, all funds received are used for research. The HCM Research Foundation supporting SLRHC has no staff expenses; all activities result from volunteer efforts. |
 |
Approximately 1 in every 500 people has Hypertrophic Cardiomyopathy causing some, including athletes, to die suddenly. Yet most people are unaware of this inherited serious heart disease and its potentially catastrophic effects.
The Hypertrophic Cardiomyopathy Research Foundation, supporting research at St. Luke's Roosevelt Hospital Center, Columbia University, New York City, was started by an ex-athlete, one of the five percent who survive a sudden cardiac arrest. It is a New York State Tax Exempt Corporation under section 501(a) of the IRS code. After accounting costs, all funds received are used for research. The HCM Research Foundation supporting SLRHC has no staff expenses; all activities result from volunteer efforts.
Our Mission: Because hypertrophic cardiomyopathy research is underfunded, we solicit contributions to fund research to attack HCM on many fronts:
- To reduce, prevent and eventually eliminate the risk of sudden death from HCM.
- Understand how HCM causes patient symptoms.
- To find treatments to relieve symptoms, to improve patients' quality of life.
- To help identify those who have HCM and those who are likely to develop it.
Our president's year end letter.
We would like to send you information: & updates from time to time, so please Click here to register your name & address.
Please help spread the word about HCM: Click here for a letter you can print and send to your contacts.
To support HCM research at St. Luke's Roosevelt Hospital Center: Send check to:
HCMRF
P.O. Box 690
Rye, NY 10580
WHAT IS HYPERTROPHIC CARDIOMYOPATHY?
HCM is an inherited heart disease. Many people with HCM have no idea that they are sick or possibly in danger. In HCM, the left ventricle, one of the heart’s four chambers, becomes thickened and muscle-bound. This reduces the amount of blood it can hold and causes symptoms. HCM can affect the duration and quality of patients’ lives. Click here to learn more.
HOW DO I KNOW IF I HAVE HCM?
HCM can be diagnosed with an echocardiogram, a non-invasive, non-X-ray imaging technique that uses sound waves to picture the heart and to assess the thickness of the heart’s walls. click here to learn more about symptoms and diagnosis of HCM
CURRENT RESEARCH ABSTRACTS
Click here to see SLRHC HCM research abstracts. Click here to read abstracts from other centers.